≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

See its core counterpart C3_OESOPHAGUS_EXALLC for full statistics.

Malignant neoplasm of oesophagus

DOID Endpoint Browser

C3_OESOPHAGUS

esophageal squamous cell carcinoma: Esophageal squamous cell carcinoma (ESCC) is a type of esophageal carcinoma (EC; see this term) that can affect any part of the esophagus, but is usually located in the upper or middle third.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Cause of death: ICD-10 — C15
  • Cause of death: ICD-9 — 150
  • Cause of death: ICD-8 — 150
  • Cancer registry: Topography ICD-O-3 — C15
  • Cancer registry: Morphology ICD-O-3 — ANY
  • Cancer registry: Behaviour codes — 3

2 out of 7 registries used, show all original rules.

849

4. Check minimum number of events

None

849

5. Include endpoints

None

849

6. Filter based on genotype QC (FinnGen only)

849

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF9

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 849 189 660
Unadjusted period prevalence (%) 0.24 0.06 0.29
Median age at first event (years) 69.47 70.14 69.28

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
782
Matched controls
7821
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
130
Kela drug reimbursment
Malignant tumour
31.5
323.0
506
430
C15.5
ICD-10 Finland
Malignant neoplasm: Lower third of oesophagus
1760.5
323.0
536
10
JCF12
NOMESCO Finland
Endoscopic insertion of prosthetic tube into oesphagus
775.5
321.0
295
6
C15.9
ICD-10 Finland
Malignant neoplasm: Oesophagus, unspecified
818.1
293.5
271
5
8070/3-C15.9
ICD-O-3
Squamous cell carcinoma, NOS, of esophagus, NOS
+∞
249.7
226
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
15.4
246.9
619
1543
A03FA01
ATC
metoclopramide; systemic, rectal
13.0
216.4
483
864
JCC12
NOMESCO Finland
Thoracoscopic or laparoscopic partial oesophagectomy
664.2
211.6
200
*
C15.4
ICD-10 Finland
Malignant neoplasm: Middle third of oesophagus
+∞
200.9
184
*
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
62.0
178.7
207
45
8140/3-C15.9
ICD-O-3
Adenocarcinoma, NOS, of esophagus, NOS
+∞
156.6
145
*
H02AB02
ATC
dexamethasone; systemic
11.7
151.3
317
431
JC2AB
NOMESCO Finland
Oesophagus X-ray examination with contrast
102.6
145.6
157
19
L01BC06
ATC
capecitabine; oral
24.6
144.1
210
115
A04AA02
ATC
granisetron; systemic, transdermal
15.4
132.6
233
210
R4190
NOMESCO Finland
Nutritional therapy
31.4
127.0
171
69
N02AA05
ATC
oxycodone; systemic
7.1
119.2
364
854
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
22.3
115.8
173
98
WX302
NOMESCO Finland
Thoracal epidural anesthesy
14.8
115.7
205
183
8140/3-C15.5
ICD-O-3
Adenocarcinoma, NOS, of lower third of esophagus
+∞
114.4
107
*
R13
ICD-10 Finland
Dysphagia
12.1
114.4
225
252
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
15.7
112.7
194
161
JN4BD
NOMESCO Finland
Extensive body CT
7.9
109.9
292
548
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
37.3
108.2
139
45
Z51.5
ICD-10 Finland
Palliative care
9.9
107.1
237
328
JD1EE
NOMESCO Finland
Ultrasound examination of gastro-oesophageal reflux
302.5
105.6
105
*
C15.3
ICD-10 Finland
Malignant neoplasm: Upper third of oesophagus
+∞
104.6
98
*
C15.1
ICD-10 Finland
Malignant neoplasm: Thoracic part of oesophagus
1051.7
97.2
93
*
WX600
NOMESCO Finland
Single shot through catheter
52.6
94.6
113
25
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
10.5
94.2
198
244
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
43.0
86.9
108
29
JCA55
NOMESCO Finland
Endoscopic dilatation of oesophagus
47.8
85.5
104
25
UJC12
NOMESCO Finland
Flexible oesophagoscopy
55.0
85.3
101
21
JCC10
NOMESCO Finland
Transthoracic partial oesophagectomy without interposition
309.7
83.3
83
*
C15.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of oesophagus
+∞
81.7
77
*
C15.0
ICD-10 Finland
Malignant neoplasm: Cervical part of oesophagus
850.6
79.9
77
*
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
18.0
77.0
123
80
A04AA01
ATC
ondansetron; systemic, rectal
9.5
75.3
166
216
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
9.5
74.5
164
213
K22.2
ICD-10 Finland
Oesophageal obstruction
29.6
73.0
99
38
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
11.0
62.7
125
133
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
7.6
59.7
151
240
WF004
NOMESCO Finland
Palliative radiotherapy
14.2
51.6
90
71
JDB10
NOMESCO Finland
Percutaneous gastrostomy
18.8
51.5
80
47
8070/3-C15.5
ICD-O-3
Squamous cell carcinoma, NOS, of lower third of esophagus
+∞
50.6
48
*
WF002
NOMESCO Finland
Radical radiotherapy
6.4
47.3
134
245
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.6
46.8
262
958
WF001
NOMESCO Finland
Preoperative radiotherapy
29.7
46.8
63
23
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.1
44.2
347
1613
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
19.0
44.1
68
39
A02BC02
ATC
pantoprazole; systemic
3.1
43.4
597
3981
ZXE40
NOMESCO Finland
More than seven and less than nine hours
10.6
43.0
86
90
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
11.0
40.4
79
79
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
27.5
39.4
54
21
A04AA55
ATC
palonosetron, combinations; systemic
14.2
39.4
68
52
D77
ICPC
Malignant digestive neopl other/NOS
40.1
39.2
49
13
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.4
38.4
226
838
WF049
NOMESCO Finland
Radiotherapy of metastasis
8.1
38.1
89
122
8070/3-C15.4
ICD-O-3
Squamous cell carcinoma, NOS, of middle third of esophagus
+∞
34.6
33
*
XX3DW
NOMESCO Finland
Time consuming IT work
3.8
34.3
161
494
ZXE30
NOMESCO Finland
More than five and less than seven hours
5.6
34.1
106
214
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
5.6
34.1
105
210
K22.1
ICD-10 Finland
Ulcer of oesophagus
10.7
34.0
67
68
C15.2
ICD-10 Finland
Malignant neoplasm: Abdominal part of oesophagus
+∞
33.6
32
*
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
58.5
33.5
39
7
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
19.7
33.1
50
27
UGC12
NOMESCO Finland
Flexible bronchoscopy
4.0
33.0
145
419
JDA55
NOMESCO Finland
Endoscopic dilatation of stomach, pylorus or anastomosis of stomach
56.9
32.5
38
7
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
5.7
31.8
97
191
UJD02
NOMESCO Finland
Gastroscopy
5.4
31.6
101
210
WW500
NOMESCO Finland
Blood transfusion
6.4
31.5
87
151
JN4AD
NOMESCO Finland
Body CT examination
4.1
31.4
133
370
WX402
NOMESCO Finland
General anaesthesia
3.4
30.9
173
607
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
17.8
30.1
47
28
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
5.5
29.5
92
186
ZX120
NOMESCO Finland
Intravenous
3.8
29.5
135
402
WZC30
NOMESCO Finland
Teaching
3.2
29.1
174
638
A04AD12
ATC
aprepitant; systemic
11.1
28.2
54
52
ZX095
NOMESCO Finland
Combined chemoradiotherapy
18.1
27.8
43
25
C16.00
ICD-10 Finland
Cardia
31.4
27.4
36
12
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
8.4
27.2
61
78
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
5.7
26.6
79
150
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
10.6
26.1
51
51
TPX10
NOMESCO Finland
Implantation of vascular injection port
7.1
25.6
64
97
D13.0
ICD-10 Finland
Benign neoplasm: Oesophagus
51.9
25.4
30
6
JN4CD
NOMESCO Finland
Very extensive body CT
5.2
25.4
82
172
RD210
NOMESCO Finland
NA
14.7
25.1
42
30
TJD20
NOMESCO Finland
Change of gastrostomy tube
38.9
24.1
30
8
B01AB05
ATC
enoxaparin; parenteral
2.3
23.8
300
1668
JCA45
NOMESCO Finland
Endoscopic mucosal or submucosal resection in oesophagus
247.2
23.8
24
*
1CD01
NOMESCO Finland
NA
55.8
23.2
27
5
JCA08
NOMESCO Finland
Endoscopic removal of foreign body from oesophagus
55.8
23.2
27
5
JDB00
NOMESCO Finland
Gastrostomy
67.1
23.0
26
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.3
22.5
124
422
WX408
NOMESCO Finland
General anesthesy, balanced
2.3
22.5
260
1379
D84
ICPC
Oesophagus disease
46.5
22.5
27
6
K22.7
ICD-10 Finland
Barrett oesophagus
12.0
22.4
41
36
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
5.2
22.0
70
144
8000/3-C15.9
ICD-O-3
Neoplasm, malignant of esophagus, NOS
+∞
22.0
21
*
A98
ICPC
Health maint/preventive medicine
0.5
21.8
485
6119
JFF00
NOMESCO Finland
Catheter enterostomy
118.3
21.7
23
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
6.7
21.3
55
87
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
9.4
21.3
44
49
WX872
NOMESCO Finland
Intensive care
3.9
21.2
92
259
8140/3-C15.2
ICD-O-3
Adenocarcinoma, NOS, of abdominal esophagus
+∞
20.9
20
*
R4110
NOMESCO Finland
Physiotherapy
2.3
20.8
249
1332
8140/3-C16.0
ICD-O-3
Adenocarcinoma, NOS, of cardia, NOS
26.3
20.5
28
11
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
5.6
20.4
61
117
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
20.3
413
2772
A02BC05
ATC
esomeprazole; systemic
2.1
19.6
340
2130
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
4.1
19.3
78
206
WX002
NOMESCO Finland
Sedation and analgesia
2.3
18.7
198
990
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
6.8
18.2
46
71
ZXE00
NOMESCO Finland
One hour or less
2.0
17.9
324
2039
K22.9
ICD-10 Finland
Disease of oesophagus, unspecified
23.4
17.8
25
11
C15
ICD-10 Finland
Malignant neoplasm of oesophagus
+∞
17.8
17
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.7
17.6
81
239
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
6.4
17.5
46
75
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.7
17.4
78
225
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
14.3
17.4
29
21
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
9.1
16.8
35
40
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
10.7
16.8
32
31
TJF00
NOMESCO Finland
Insertion of jejunal tube
64.8
16.8
19
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
5.9
16.7
47
84
RD160
NOMESCO Finland
NA
92.0
16.6
18
*
K92.0
ICD-10 Finland
Haematemesis
5.5
16.6
49
93
C16.09
ICD-10 Finland
Malignant tumor of cardiac or other unspecified carcinoma
20.6
16.5
24
12
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
4.0
16.3
67
180
1505A
ICD-9 Finland
Malignant neoplasm of oesophagus, Lower third of oesophagus
+∞
15.7
15
*
T18.1
ICD-10 Finland
Foreign body in oesophagus
12.1
15.6
28
24
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
5.7
15.6
45
83
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
5.8
15.6
44
79
A06AH03
ATC
naloxegol; oral
7.5
15.4
36
50
ZXD05
NOMESCO Finland
Urgent procedure
2.0
15.4
269
1648
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
23.9
15.2
21
9
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
15.1
200
1097
JCA98
NOMESCO Finland
Other local endoscopic operation on oesophagus
32.4
14.9
19
6
L03
ICPC
Low back symptom/complaint
0.3
14.5
34
1021
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
15.7
14.5
23
15
L03AA13
ATC
pegfilgrastim; parenteral
4.9
14.0
46
99
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
76.5
13.6
15
*
JCC30
NOMESCO Finland
Transthoracic partial oesophagectomy with interposition of intestine
+∞
13.6
13
*
8070/3-C15.3
ICD-O-3
Squamous cell carcinoma, NOS, of upper third of esophagus
+∞
13.6
13
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
4.6
13.4
46
104
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
4.0
13.4
53
138
R11
ICD-10 Finland
Nausea and vomiting
3.1
13.3
75
258
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
14.1
13.3
22
16
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
11.8
12.9
23
20
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.3
12.8
130
629
L03AA02
ATC
filgrastim; parenteral
4.7
12.7
43
96
JCF00
NOMESCO Finland
Insertion of prosthetic tube into oesphagus
+∞
12.5
12
*
8144/3-C15.9
ICD-O-3
Adenocarcinoma, intestinal type of esophagus, NOS
+∞
12.5
12
*
JCC00
NOMESCO Finland
Transhiatal partial oesophagectomy without interposition
+∞
12.5
12
*
Z3226
NOMESCO Finland
Physiotherapist
2.1
12.5
158
840
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
8.9
12.1
25
29
A79
ICPC
Malignancy NOS
7.0
12.0
29
43
K22.3
ICD-10 Finland
Perforation of oesophagus
47.4
11.9
14
*
ZXD10
NOMESCO Finland
Scheduled procedure
1.7
11.7
304
2086
JCB00
NOMESCO Finland
Oesophagostomy
+∞
11.5
11
*
D00.1
ICD-10 Finland
Carcinoma in situ: Oesophagus
121.7
11.5
12
*
JFF01
NOMESCO Finland
Laparoscopic catheter enterostomy
121.7
11.5
12
*
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
5.9
11.4
31
54
JAH00
NOMESCO Finland
Laparotomy
4.5
11.2
39
90
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
12.9
11.2
19
15
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
3.4
11.1
53
163
WB111
NOMESCO Finland
Multiple neoadjuvant cytostatic therapy
43.9
10.9
13
*
Z43.1
ICD-10 Finland
Attention to gastrostomy
60.8
10.6
12
*
JCA52
NOMESCO Finland
Other endoscopic procedure using diathermy or heat in oesophagus
60.8
10.6
12
*
R52.0
ICD-10 Finland
Acute pain
5.0
10.6
33
68
GBA35
NOMESCO Finland
Endoscopic insertion of stent into trachea
111.4
10.4
11
*
8010/3-C15.9
ICD-O-3
Carcinoma, NOS, of esophagus, NOS
+∞
10.4
10
*
8144/3-C15.5
ICD-O-3
Adenocarcinoma, intestinal type of lower third of esophagus
+∞
10.4
10
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
9.7
10.3
20
21
J01MA12
ATC
levofloxacin; systemic
1.8
10.2
185
1124
Z98.8
ICD-10 Finland
Other specified postsurgical states
7.4
10.0
23
32
GBB00
NOMESCO Finland
Tracheostomy
6.3
9.7
25
41
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
0.5
9.5
81
1487
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
30.4
9.4
12
*
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
3.4
9.4
45
139
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
12.5
9.4
16
13
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.4
9.4
44
134
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
8.8
9.3
19
22
C10AA07
ATC
rosuvastatin; oral
0.5
9.3
71
1348
JAH01
NOMESCO Finland
Laparoscopy
4.1
9.2
35
89
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.2
9.1
94
455
GD1AD
NOMESCO Finland
Thorax CT examination
3.0
9.1
52
182
L01BC53
ATC
tegafur, combinations; systemic
37.1
9.0
11
*
A06AD11
ATC
lactulose; oral
1.9
8.9
151
889
UGB02
NOMESCO Finland
Tracheoscopy
24.3
8.9
12
5
D21
ICPC
Swallowing problem
5.7
8.8
24
43
N03AX16
ATC
pregabalin; oral
1.8
8.8
178
1111
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
7.3
8.8
20
28
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
6.7
8.7
21
32
N05BA06
ATC
lorazepam; systemic, sublingual
2.7
8.7
58
224
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.7
8.6
239
1639
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
4.0
8.6
33
85
GAB10
NOMESCO Finland
Antero- or postero-lateral thoracotomy
9.6
8.3
16
17
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
0.5
8.2
62
1184
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
0.5
8.1
93
1567
178
Kela drug reimbursment
Combination product containing tegafur, gimeracil and oteracil
33.7
8.1
10
*
R4130
NOMESCO Finland
Speech therapy
4.3
7.8
27
64
N02AA03
ATC
hydromorphone; systemic, rectal
15.2
7.7
12
8
SPAT1109
SPAT
Analgesia with portable analgesic pump
8.1
7.6
16
20
C16.04
ICD-10 Finland
Malignant tumor of cardiac intestinal carcinoma
18.6
7.6
11
6
C16.03
ICD-10 Finland
Malignant tumor of cardiac diffuse carcinoma
25.3
7.6
10
*
B01AB10
ATC
tinzaparin; parenteral
2.4
7.5
64
285
8144/3-C16.0
ICD-O-3
Adenocarcinoma, intestinal type of cardia, NOS
80.8
7.4
8
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
4.1
7.3
27
68
1504A
ICD-9 Finland
Malignant neoplasm of oesophagus, Middle third of oesophagus
+∞
7.3
7
*
GCA32
NOMESCO Finland
Endoscopic insertion of stent into bronch
+∞
7.3
7
*
L15
ICPC
Knee symptom/complaint
0.4
7.3
42
879
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
3.6
7.3
31
89
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
15.9
7.2
11
7
T05
ICPC
Feeding problem of adult
7.4
7.2
16
22
R63.8
ICD-10 Finland
Other symptoms and signs concerning food and fluid intake
20.2
7.1
10
5
K20
ICD-10 Finland
Oesophagitis
4.6
7.1
23
51
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
8.9
7.1
14
16
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
7.1
7.0
16
23
M25.5
ICD-10 Finland
Pain in joint
0.5
6.9
61
1113
N40
ICD-10 Finland
Hyperplasia of prostate
0.6
6.8
133
1975
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
6.2
6.8
17
28
I50.0
ICD-10 Finland
Congestive heart failure
0.3
6.7
18
513
Z2221
NOMESCO Finland
Medical doctor
1.6
6.7
193
1324
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.5
6.6
51
976
C10AA05
ATC
atorvastatin; oral
0.6
6.6
187
2561
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
4.9
6.6
20
42
I50.1
ICD-10 Finland
Left ventricular failure
0.2
6.5
6
303
L17
ICPC
Foot/toe symptom/complaint
0.5
6.5
68
1185
N02AA01
ATC
morphine; systemic, rectal
3.9
6.5
25
66
J86.9
ICD-10 Finland
Pyothorax without fistula
5.8
6.5
17
30
JX1XB
NOMESCO Finland
Other X-ray examination of alimentary tract with contrast
70.4
6.4
7
*
ZYB02
NOMESCO Finland
Outreach service at unit of another specialty
70.4
6.4
7
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
3.5
6.3
27
79
6312
FHL
Gastrostomy
+∞
6.3
6
*
8070/3-C15.0
ICD-O-3
Squamous cell carcinoma, NOS, of cervical esophagus
+∞
6.3
6
*
8480/3-C15.5
ICD-O-3
Mucinous adenocarcinoma of lower third of esophagus
+∞
6.3
6
*
8246/3-C15.9
ICD-O-3
Neuroendocrine carcinoma, NOS, of esophagus, NOS
+∞
6.3
6
*
JCC96
NOMESCO Finland
Other partial oesophagectomy
26.9
6.2
8
*
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
0.6
6.2
110
1670
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
5.8
6.2
16
28
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
3.2
6.1
30
97
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
12.6
6.1
10
8
AA1BD
NOMESCO Finland
Extensive CT of head and brain
3.2
6.1
29
92
XKD00
NOMESCO Finland
Uroflowmetry
0.6
6.1
77
1275
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
0.6
6.0
141
2018

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768797) Stomach Pathology biopsy report
451
901
9.54
245.49
2.2
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
411
834
8.61
216.85
4.8
4.3
ug/l
37.1
20.9
0.46
375
711
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
199
313
8.00
126.85
4.0
3.7
u/ml
1086.4
12806.6
0.70
189
259
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
146
169
10.23
119.36
4.4
3.5
u/ml
597.2
350.5
0.26
133
159
(3012095) Magnesium [Moles/volume] in Serum or Plasma
377
1212
4.80
108.74
5.4
3.6
mmol/l
0.8
0.8
11.10
370
1138
(4035726)
223
625
4.48
73.42
1.5
1.4
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
241
742
4.14
69.59
2.9
2.2
g/l
0.2
0.2
2.82
231
681
(3003458) Phosphate [Moles/volume] in Serum or Plasma
290
1021
3.80
68.98
5.1
6.4
mmol/l
0.9
1.0
8.18
281
950
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
45
21
22.57
60.75
1.0
1.0
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
546
3101
3.13
55.41
9.6
5.2
g/l
31.1
34.7
32.65
535
2876
(3044640) Blood type and Crossmatch panel - Blood
430
2243
2.86
49.17
4.9
2.7
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
428
2259
2.80
47.35
5.4
4.7
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
346
1714
2.72
42.21
3.9
2.6
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
199
734
3.24
41.67
3.7
8.2
mmol/l
6.7
11.0
17.26
189
697
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
430
6114
0.40
37.48
5.5
6.5
mmol/mol
40.5
41.1
0.73
378
5581
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
561
3642
2.59
37.39
14.1
6.8
umol/l
10.5
12.8
5.44
554
3462
(3032080) INR in Blood by Coagulation assay
512
3242
2.46
35.11
8.9
11.6
inr
1.2
1.4
5.02
112
913
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
473
6408
0.41
34.73
3.9
5.4
mmol/l
2.5
2.6
0.24
412
5766
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
459
6257
0.42
32.96
3.5
4.8
mmol/l
4.4
4.4
0.13
410
5687
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
453
6196
0.42
32.44
3.5
4.8
mmol/l
1.4
1.4
0.42
398
5578
(3015377) Calcium [Moles/volume] in Serum or Plasma
396
2334
2.31
30.68
6.4
3.5
mmol/l
2.3
2.3
0.24
366
2000
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
102
299
3.74
30.13
2.5
2.6
u/ml
0.3
0.3
2.15
58
170
(3000492) Spirometry study
148
563
2.97
28.62
1.3
1.5
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
536
3722
2.19
26.11
15.3
9.2
e9/l
4.2
4.3
0.13
499
3242
(40758558) Short blood count panel - Blood
289
1597
2.23
25.04
11.1
6.8
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
478
3211
2.12
24.91
6.1
4.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
460
6002
0.49
22.37
3.4
4.3
mmol/l
1.3
1.3
0.16
408
5380
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
251
1376
2.17
21.67
7.0
3.3
mmol/l
2.5
2.5
10.60
230
1197
(3002256) Pathology report gross observation
177
894
2.24
18.41
1.6
1.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
126
554
2.50
17.95
1.6
1.7
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
214
1207
2.03
16.54
1.7
2.1
s
30.0
30.0
0.02
209
1168
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
284
4105
0.54
15.83
3.8
5.2
ug/l
2.3
3.1
1.44
242
3638
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
316
2066
1.84
15.52
4.0
3.4
u/l
32.9
34.5
0.45
309
1956
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
208
3292
0.51
15.46
3.7
4.5
%
21.8
21.3
0.21
96
1694
(40768804) Tissue Pathology biopsy report
361
2492
1.78
14.57
3.3
2.3
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
324
2178
1.79
14.23
2.8
2.6
u/l
53.7
57.6
0.89
312
2019
(3013826) Glucose [Moles/volume] in Serum or Plasma
542
4256
1.76
13.48
9.6
5.2
mmol/l
6.7
6.9
2.33
532
4020
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
451
5611
0.58
13.23
3.8
4.3
mu/l
2.0
2.0
0.07
395
4973
(1761868) Lipid panel - Serum or Plasma
103
1976
0.46
12.86
2.6
3.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
331
4419
0.59
12.29
3.4
3.5
pmol/l
15.2
15.1
0.24
296
3885
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
461
3533
1.67
11.86
10.7
7.4
mmol/l
1.2
1.2
0.85
390
2953
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
82
362
2.40
11.46
2.3
2.0
ug/l
0.9
2.3
0.95
74
322
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
92
1770
0.46
11.33
1.6
1.7
mmol/l
1.2
1.4
1.24
79
1431
(3003694) ABO and Rh group [Type] in Blood
257
1709
1.72
11.18
1.3
1.3
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
165
963
1.89
11.11
14.4
7.6
mmol/l
1.6
1.0
0.95
149
738
(3014111) Lactate [Moles/volume] in Serum or Plasma
130
705
2.00
10.86
13.1
7.5
mmol/l
1.3
1.4
1.45
125
676
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
95
463
2.18
10.53
1.7
1.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
147
2374
0.54
10.45
2.7
3.2
ug/l
0.7
0.8
0.93
102
1655
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
424
3259
1.60
10.19
10.0
6.5
mmol/l
1.2
1.2
3.03
400
2943
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
539
6272
0.61
9.97
4.3
5.0
mmol/l
6.1
6.1
0.60
498
5594
(3012516) Albumin [Mass/volume] in Urine
143
2292
0.55
9.76
2.7
3.4
mg/l
65.8
285.6
2.27
96
1552
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
101
529
2.03
9.26
17.4
9.6
%
0.7
0.7
0.50
101
524
(3020682) Albumin/Creatinine [Ratio] in Urine
158
2432
0.57
9.21
3.5
4.0
mg/mmol
10.8
9.6
0.11
104
1610
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
101
536
2.00
8.92
17.4
9.4
%
1.3
1.4
0.07
101
531
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
87
446
2.06
8.45
18.3
10.5
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
604
5180
1.58
8.07
14.9
8.1
u/l
95.0
80.2
6.72
589
4845
(3000991) Gas panel - Venous blood
116
667
1.86
8.06
15.3
9.0
—
—
—
0
0
(3018418) pH of Serum or Plasma
287
2108
1.55
7.84
5.0
4.4
ph
7.4
7.4
0.51
66
428
(3009508) Creatinine [Moles/volume] in Urine
156
2318
0.60
7.62
2.5
3.2
mmol/l
7.5
7.8
0.32
125
1913
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
130
791
1.76
7.48
2.6
2.9
umol/l
10.5
10.4
0.01
119
706
(3010813) Leukocytes [#/volume] in Blood
630
6955
0.63
7.28
48.3
25.4
e9/l
7.4
6.9
5.61
610
6711
(3000963) Hemoglobin [Mass/volume] in Blood
630
6954
0.64
7.25
48.5
25.5
g/l
118.1
135.7
108.99
619
6807
(3026361) Erythrocytes [#/volume] in Blood
630
6953
0.64
7.23
48.1
25.4
e12/l
4.0
4.5
70.75
612
6705
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
40
905
0.41
7.22
1.1
1.3
iu/ml
66.4
45.8
0.47
13
271
(3024731) MCV [Entitic volume]
630
6952
0.64
7.21
48.0
25.3
fl
91.6
91.8
0.27
621
6811
(3035941) MCH [Entitic mass]
630
6952
0.64
7.21
48.0
25.3
pg
30.2
30.6
4.70
621
6810
(3007461) Platelets [#/volume] in Blood
630
6951
0.64
7.18
48.2
25.4
e9/l
263.5
234.7
14.67
614
6734
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
109
639
1.81
7.11
2.1
2.5
u/l
32.1
40.8
0.60
93
550
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
38
857
0.42
6.80
1.1
1.2
u/ml
2.3
12.7
3.27
15
300
(3009261) Glucose [Presence] in Urine by Test strip
245
3152
0.69
5.66
3.1
3.8
estimate
0.0
0.0
0.00
55
583
(3006504) Eosinophils/100 leukocytes in Blood
371
3021
1.41
5.48
4.3
6.0
%
2.3
2.9
5.03
352
2803
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
182
1300
1.51
5.39
1.7
2.0
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
245
3129
0.69
5.35
3.1
3.8
estimate
0.0
0.0
0.00
53
612
(3022948) Iron [Moles/volume] in Serum or Plasma
169
1191
1.52
5.33
2.0
2.7
umol/l
9.5
12.6
5.56
163
1099
(3019069) Monocytes/100 leukocytes in Blood
371
3036
1.39
5.26
4.4
6.3
%
9.4
9.1
0.51
351
2822
(3002030) Lymphocytes/100 leukocytes in Blood
376
3085
1.39
5.24
4.4
6.2
%
20.2
26.0
17.69
358
2853
(3021601) Nitrite [Presence] in Urine by Test strip
244
3109
0.70
5.22
4.3
5.1
estimate
0.0
0.0
0.00
54
621
(40768806) Pleura Pathology biopsy report
29
115
2.58
5.17
1.4
1.6
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
618
6737
0.70
4.99
18.0
11.5
u/l
24.1
26.8
3.28
601
6457
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
12
403
0.29
4.98
2.3
2.5
—
11.6
—
0
13
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
237
3016
0.70
4.96
2.3
2.3
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
285
2253
1.40
4.87
4.0
5.9
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
625
6789
0.70
4.80
40.9
20.9
mmol/l
3.9
4.0
14.34
615
6591
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
36
164
2.25
4.78
1.2
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
36
164
2.25
4.78
1.2
1.4
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
358
2948
1.37
4.74
4.3
6.0
%
0.6
0.6
0.58
340
2741
(3004789) Transferrin [Mass/volume] in Serum or Plasma
155
1104
1.49
4.61
1.8
2.7
g/l
2.3
2.2
0.41
146
1023
(3028717) Thiamine [Mass/volume] in Blood
7
5
14.10
4.58
1.7
1.4
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
625
6772
0.71
4.51
40.6
20.7
mmol/l
138.1
139.6
30.67
616
6581
(3020891) Body temperature
60
338
1.83
4.49
6.4
4.7
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
415
4783
0.74
4.45
2.9
4.1
mm/h
18.4
13.8
5.08
368
4353
(3042936) Bacteria identified in Isolate by Culture
158
1140
1.47
4.40
2.3
2.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
549
6064
0.73
4.37
34.8
16.2
ml/min/173m2
86.5
74.9
36.40
509
5089
(3007853) Bacteria identified in Skin by Aerobe culture
125
861
1.53
4.35
1.8
1.8
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
35
689
0.49
4.35
2.1
2.2
nmol/l
10.4
12.9
1.20
27
600
(3026493) Urate [Moles/volume] in Serum or Plasma
142
1944
0.68
4.33
2.4
3.0
umol/l
4410.9
7874.2
0.38
118
1658
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
167
2204
0.70
4.15
1.8
2.3
u/l
216.5
270.4
0.58
159
2063
(3018405) Lactate [Moles/volume] in Arterial blood
56
317
1.82
4.14
7.6
3.9
mmol/l
1.2
1.4
1.35
56
311
(3018010) Neutrophils/100 leukocytes in Blood
361
3028
1.33
4.06
4.4
5.9
%
63.7
58.4
10.92
344
2819
(3012501) Base excess in Blood by calculation
38
190
2.05
4.04
6.1
5.7
mmol/l
3.4
2.4
0.98
27
135
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
33
157
2.15
3.99
1.1
1.3
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
12
356
0.33
3.98
1.2
1.4
—
53.8
—
0
21
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
11
341
0.31
3.97
1.6
1.8
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
146
1058
1.46
3.97
1.9
2.7
%
17.0
22.6
4.60
127
897
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
86
556
1.61
3.95
5.2
2.9
ml/min/173m2
73.3
60.9
1.80
31
227
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
238
1884
1.37
3.89
2.1
2.2
mg/l
3.8
3.1
2.10
205
1582
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
129
917
1.48
3.86
1.8
1.9
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
383
3261
1.32
3.80
4.3
5.9
e9/l
1.5
1.9
2.55
330
2858
(40761511) CBC panel - Blood by Automated count
604
6530
0.74
3.72
32.3
16.9
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
187
1433
1.39
3.72
3.3
4.1
ng/l
191.4
399.8
0.98
162
1230
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
12
35
3.46
3.63
1.8
3.5
u/ml
23.2
64.2
0.77
12
35
(3028308) Erythrocytes [#/volume] in Pleural fluid
24
105
2.32
3.55
1.4
1.4
e6/l
77526.9
22020.5
0.33
16
64
(3026782) Osmolality of Urine
196
1525
1.37
3.54
2.5
3.0
mosm/kgh2o
519.2
572.3
2.93
179
1294
(3023199) Leukocytes [#/volume] in Pleural fluid
26
119
2.22
3.47
1.4
1.4
e6/l
1071.2
1581.5
0.60
20
84
(3013115) Eosinophils [#/volume] in Blood
385
3309
1.30
3.47
4.4
5.9
e9/l
0.2
0.2
3.48
332
2894
(40768795) Lymph node Pathology biopsy report
17
64
2.69
3.41
1.1
1.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
193
2421
0.74
3.40
3.2
4.1
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
374
3209
1.30
3.39
4.2
5.8
e9/l
0.0
0.0
0.37
321
2756
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
126
918
1.44
3.32
1.7
1.8
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
275
2272
1.31
3.29
2.9
3.5
e6/l
47.4
113.4
1.37
229
1806
(3045788) Cell count panel - Pleural fluid
21
90
2.37
3.26
1.4
1.4
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
12
38
3.19
3.22
1.8
2.4
—
—
—
0
0
(3012544) pH of Venous blood
107
761
1.46
3.20
3.2
3.9
—
7.4
—
0
5
(3001604) Monocytes [#/volume] in Blood
371
3197
1.29
3.20
4.1
5.8
e9/l
0.7
0.6
3.42
318
2732
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
74
1089
0.65
3.18
1.2
1.2
u/ml
4.9
1.4
0.54
17
282
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
19
79
2.44
3.15
3.1
3.0
nmol/l
7.8
5.6
0.18
19
79
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
7
216
0.32
3.08
1.1
1.3
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
252
2073
1.31
3.08
2.9
3.4
e6/l
1.1
0.6
0.39
207
1602
(3007164) IgA [Mass/volume] in Serum or Plasma
71
1044
0.65
3.04
1.3
1.5
g/l
3.6
2.8
0.94
37
631
(3037522) Nuclear Ab [Titer] in Serum
47
746
0.61
2.82
1.1
1.3
titre
581.3
408.0
0.22
15
169
(3002032) Base excess in Venous blood by calculation
101
732
1.43
2.76
3.2
3.8
mmol/l
3.4
1.9
2.09
78
575
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
9
230
0.38
2.71
1.1
1.3
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
11
37
3.00
2.70
3.1
3.9
nmol/l
115.2
82.0
0.24
11
37
(1002224) Polysomnography panel
6
184
0.32
2.70
1.2
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
24
119
2.05
2.68
2.4
2.3
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
34
191
1.81
2.66
1.6
2.2
%
78.4
85.0
0.72
34
181
(3041096) Erythrocytes [Presence] in Urine by Automated
130
1673
0.74
2.64
3.1
3.6
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
12
44
2.75
2.55
1.1
1.1
nmol/l
115.4
135.2
0.62
12
44
(21494755) Public health laboratory ask at order entry panel
12
284
0.41
2.51
1.1
1.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
236
1971
1.27
2.50
2.9
3.4
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
13
51
2.57
2.45
6.9
4.1
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
30
514
0.57
2.45
1.4
2.5
g/l
11.3
10.9
0.15
25
471
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
62
895
0.67
2.44
3.6
4.8
%
30.4
31.9
0.70
42
592
(40768800) Prostate Pathology biopsy report
11
266
0.41
2.43
1.2
1.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
26
138
1.91
2.43
2.7
3.2
%
65.2
58.2
1.62
26
138
(3048689) Calprotectin [Mass/mass] in Stool
35
572
0.60
2.39
2.0
2.3
ug/g
218.3
146.4
0.39
29
463
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
8
202
0.39
2.31
1.8
1.8
nmol/l
41.1
42.4
—
8
192
(3042111) Morphology [Interpretation] in Bone marrow Narrative
5
153
0.32
2.30
1.6
1.7
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
151
1203
1.31
2.29
2.6
3.2
e6/l
2.2
1.3
0.82
94
724
(3049717) Cytology report of Urine Cyto stain
22
404
0.53
2.29
2.8
2.9
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
16
72
2.25
2.28
1.9
1.5
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
15
312
0.47
2.27
1.0
1.3
—
33.8
—
0
7
(3045414) Leukocytes [Presence] in Urine
13
285
0.45
2.27
2.0
1.9
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
100
750
1.38
2.27
1.8
2.7
ug/l
4.0
7.6
3.60
85
672
(3024139) IgG subclass 3 [Mass/volume] in Serum
0
59
0.00
2.25
0.0
1.3
—
0.4
—
0
39
(3028192) IgG subclass 2 [Mass/volume] in Serum
0
59
0.00
2.25
0.0
1.3
—
2.9
—
0
41
(3027135) IgG subclass 1 [Mass/volume] in Serum
0
59
0.00
2.25
0.0
1.3
—
7.4
—
0
40
(3020630) Protein [Mass/volume] in Serum or Plasma
91
673
1.39
2.24
2.1
3.0
g/l
59.1
65.8
6.90
85
612
(4062490)
0
61
0.00
2.24
0.0
1.2
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
9
29
3.13
2.23
1.3
1.3
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
195
1613
1.27
2.22
2.3
2.7
e6/l
7.0
4.0
1.38
182
1412
(3022621) pH of Urine by Test strip
26
450
0.56
2.22
1.9
2.9
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
21
108
1.97
2.17
1.2
1.4
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
208
2458
0.80
2.16
2.2
2.2
nmol/l
72.6
77.4
1.71
189
2141
(3022217) INR in Platelet poor plasma by Coagulation assay
138
1099
1.31
2.11
17.2
27.9
inr
1.3
1.4
0.29
24
149
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
8
193
0.41
2.06
1.1
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
7
175
0.40
2.05
1.1
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
39
595
0.64
2.02
1.4
1.5
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
9
32
2.83
2.00
1.8
2.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
35
217
1.64
2.00
4.7
3.8
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
117
1468
0.76
1.97
2.9
3.7
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
29
172
1.71
1.95
1.7
2.4
%
247.8
207.3
1.36
29
161
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
8
185
0.43
1.95
1.3
1.3
g/l
1.3
1.2
—
8
177
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
53
0.00
1.87
0.0
1.5
—
275.0
—
0
6
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
47
319
1.50
1.85
1.7
2.0
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
10
40
2.52
1.84
2.6
1.9
—
—
—
0
0
(4094501)
8
181
0.44
1.83
1.1
1.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
37
239
1.57
1.82
1.3
1.3
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
12
53
2.28
1.81
1.2
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
6
150
0.40
1.78
1.2
1.2
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
12
243
0.49
1.74
1.5
1.6
—
140.0
—
0
11
(3030905) Polymorphonuclear cells [#/volume] in Blood
23
133
1.75
1.71
2.5
2.8
e9/l
5.4
4.6
0.62
23
133
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
0
47
0.00
1.71
0.0
1.1
—
5.0
—
0
10
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
8
179
0.44
1.70
1.3
1.3
g/l
0.2
0.2
—
8
169
(3018095) Leukocytes [#/volume] in Urine
288
2547
1.20
1.70
3.3
4.0
e6/l
68.1
131.4
0.98
233
1910
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
36
235
1.56
1.70
1.6
1.7
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
0
49
0.00
1.68
0.0
1.4
—
55.0
—
0
8
(3019060) Gas panel - Arterial blood
76
575
1.35
1.68
9.6
4.7
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
42
285
1.50
1.67
1.5
1.8
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
14
69
2.05
1.65
1.1
1.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
214
2460
0.83
1.64
2.5
3.2
ng/l
1396.1
1805.1
1.45
189
2148
(3023520) Reticulocytes [#/volume] in Blood
53
727
0.71
1.63
2.3
2.7
e9/l
89.5
68.6
1.33
41
580
(36660697) Celiac disease serology panel - Serum
23
373
0.61
1.59
1.2
1.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
38
551
0.68
1.59
1.3
2.6
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
114
1396
0.79
1.59
2.8
4.2
kg/l
1.0
1.0
0.13
15
221
(3029937) Albumin [Presence] in Urine by Test strip
149
1767
0.81
1.56
3.0
4.1
estimate
0.0
0.0
0.50
47
578
(3033705) Calcium.ionized [Moles/volume] in Venous blood
19
107
1.79
1.55
2.4
3.0
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
14
71
1.99
1.54
1.2
1.9
—
—
—
0
0
(4034850)
11
219
0.50
1.54
13.7
12.3
—
—
—
0
0
(3012565) Volume of 24 hour Urine
0
43
0.00
1.52
0.0
3.0
—
2012.7
—
0
35
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
44
0.00
1.51
0.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
44
0.00
1.51
0.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
44
0.00
1.51
0.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
45
0.00
1.50
0.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
45
0.00
1.50
0.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
45
0.00
1.50
0.0
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
20
116
1.74
1.49
1.4
1.6
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
5
16
3.14
1.44
1.0
1.3
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
79
617
1.31
1.43
6.1
4.5
mmol/l
1.2
1.2
0.24
74
538
(3039443) Prostate specific Ag panel - Serum or Plasma
10
200
0.49
1.43
1.6
1.7
—
—
—
0
0
(40768443) Skin Pathology biopsy report
17
286
0.59
1.38
1.4
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5
123
0.40
1.37
1.0
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
5
124
0.40
1.37
1.0
4.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
20
120
1.68
1.35
1.3
1.7
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
7
150
0.46
1.32
1.6
1.9
pmol/l
163.0
217.5
—
7
138
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
21
129
1.64
1.31
1.4
1.5
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
14
76
1.86
1.30
6.9
4.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
132
0.45
1.29
1.2
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
6
133
0.45
1.29
1.0
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
6
134
0.44
1.28
3.0
1.6
—
—
—
0
0
(3019225) pH of Specimen
88
711
1.27
1.25
4.4
4.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
5
118
0.42
1.25
1.6
1.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
23
147
1.58
1.24
1.4
1.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
20
312
0.63
1.22
1.4
1.4
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
478
5067
0.87
1.22
43.7
21.2
%
15.1
13.9
28.70
468
4954
(3037756) Immunofixation for Serum or Plasma
10
188
0.53
1.22
1.1
1.5
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
20
124
1.63
1.21
1.5
1.6
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
29
197
1.49
1.20
1.3
1.6
ug/g
282.8
256.1
0.39
22
120
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
23
149
1.56
1.18
1.3
2.0
—
—
—
0
0
(3035880) pH of Pleural fluid
11
57
1.94
1.17
1.1
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
41
551
0.73
1.16
1.2
1.6
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
35
0.00
1.15
0.0
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
16
95
1.70
1.14
1.4
1.9
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
5
114
0.44
1.13
1.2
1.6
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
9
163
0.55
1.09
1.0
1.2
mg/l
435.7
531.4
—
9
151
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
5
21
2.39
1.09
1.2
1.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
28
194
1.46
1.08
3.2
4.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
13
74
1.77
1.07
1.1
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
6
123
0.48
1.05
1.2
1.3
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
6
123
0.48
1.05
1.0
1.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
146
1269
1.18
1.04
2.5
3.0
e6/l
2.1
1.0
1.49
87
782
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
311
0.67
1.04
1.4
2.7
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
311
0.67
1.04
1.4
2.7
g/l
4.1
3.8
0.64
16
218
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
311
0.67
1.04
1.4
2.7
g/l
7.2
7.3
0.20
16
226
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
9
46
1.97
1.03
1.7
1.8
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
9
46
1.97
1.03
1.7
1.8
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
53
669
0.78
0.99
1.2
1.6
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
9
157
0.57
0.99
1.6
2.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
59
733
0.79
0.97
1.3
1.3
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
30
0.00
0.97
0.0
2.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
30
0.00
0.97
0.0
1.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
14
223
0.62
0.97
1.0
1.0
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
31
0.00
0.96
0.0
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
28
200
1.41
0.94
1.5
1.5
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
11
184
0.59
0.93
1.8
1.7
e6/l
10045.8
16044.3
—
6
140
(3003327) Ova and parasites identified in Stool by Light microscopy
8
146
0.54
0.93
1.6
1.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
74
890
0.82
0.92
13.1
8.4
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
12
195
0.61
0.91
1.5
1.6
iu/ml
0.1
0.1
—
5
39
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
13
207
0.62
0.91
1.6
1.4
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
62
505
1.25
0.87
1.8
1.7
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
6
31
1.94
0.84
1.0
1.1
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
8
137
0.58
0.84
1.0
1.2
mmol/l
3.5
3.9
—
8
126
(3021788) Differential panel - Synovial fluid
8
137
0.58
0.84
1.4
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
27
197
1.38
0.83
1.3
1.8
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
8
46
1.75
0.82
1.1
1.7
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
8
46
1.75
0.82
1.1
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
47
586
0.79
0.82
1.3
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
9
147
0.61
0.79
1.4
1.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
373
3949
0.90
0.79
3.2
3.4
u/l
91.1
61.3
2.46
352
3629
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
292
2715
1.12
0.79
2.9
3.4
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
25
0.00
0.79
0.0
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
8
48
1.67
0.79
1.3
1.3
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
26
0.00
0.78
0.0
1.0
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
167
1503
1.14
0.78
2.0
1.8
nmol/l
1187.5
1178.0
0.04
133
1135
(3026008) Bacteria identified in Urine by Culture
216
1976
1.12
0.77
2.6
3.3
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
27
0.00
0.77
0.0
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
10
59
1.70
0.76
1.3
1.2
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
9
53
1.71
0.75
1.1
1.2
nmol/l
316.3
344.6
—
9
46
(3014271) Vancomycin [Susceptibility]
9
53
1.71
0.75
2.4
2.6
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
5
24
2.09
0.74
4.2
2.1
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
108
946
1.16
0.74
2.8
4.3
u/l
236.9
247.2
0.35
102
890
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
27
202
1.35
0.73
1.3
1.8
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
6
108
0.55
0.72
1.0
1.4
—
140.4
—
0
19
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
11
68
1.63
0.72
1.1
1.2
%
120.6
108.0
0.53
11
62
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
58
1.56
0.70
1.7
1.7
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
10
61
1.65
0.68
1.3
1.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
21
284
0.73
0.68
2.5
3.1
g/l
0.2
0.3
0.40
13
118
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
41
330
1.25
0.67
2.2
2.9
—
—
—
0
0
(4146454)
5
95
0.52
0.66
1.6
2.7
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
5
28
1.79
0.66
1.8
2.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
18
128
1.42
0.66
2.5
2.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
21
154
1.37
0.65
1.1
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
10
62
1.62
0.65
1.4
1.3
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
11
71
1.56
0.62
1.5
1.7
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
10
63
1.59
0.62
1.3
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
10
63
1.59
0.62
1.3
1.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
8
51
1.57
0.60
1.3
1.4
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
20
0.00
0.60
0.0
1.4
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
20
0.00
0.60
0.0
2.3
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
1.4
—
0.1
—
0
13
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
22
0.00
0.59
0.0
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
47
561
0.83
0.59
1.2
1.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
7
113
0.62
0.58
1.4
1.4
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
7
116
0.60
0.58
1.4
2.3
pg
29.9
32.9
—
7
116
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
622
6370
0.91
0.56
36.1
17.6
mg/l
44.4
28.4
20.70
600
5212
(44790049)
13
90
1.45
0.55
1.1
1.6
—
—
—
0
0
(44790047)
13
90
1.45
0.55
1.1
1.6
—
—
—
0
0
(44806118)
13
90
1.45
0.55
1.1
1.6
—
—
—
0
0
(44790048)
13
90
1.45
0.55
1.1
1.6
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
8
126
0.63
0.54
1.1
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
28
349
0.80
0.54
1.1
1.2
—
—
—
0
0
(4306422)
11
74
1.49
0.53
1.2
1.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
17
226
0.75
0.52
1.2
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
9
63
1.43
0.52
1.3
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
6
96
0.62
0.52
1.5
1.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
146
1585
0.90
0.50
1.7
1.8
pmol/l
417.8
23507020.2
1.21
122
1289
(4010399)
38
454
0.83
0.50
1.1
1.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
54
625
0.85
0.50
2.0
3.4
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
6
41
1.47
0.50
4.3
4.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
12
84
1.43
0.49
6.0
3.9
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
10
143
0.70
0.48
1.0
1.3
—
456.7
—
0
6
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
48
557
0.85
0.47
3.1
3.7
kpa
5.3
5.1
0.74
43
514
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
24
191
1.26
0.47
1.5
1.6
—
—
—
0
0
(3013512) EKG study
210
2232
0.92
0.46
4.4
4.3
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
45
523
0.85
0.45
2.8
3.8
mmol/l
3.2
1.8
1.10
37
394
(3017569) Oxygen content in Arterial blood
7
50
1.40
0.45
11.0
1.9
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
7
50
1.40
0.45
1.4
3.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
148
1371
1.10
0.45
1.6
1.7
mg/l
2.3
1.4
1.69
123
1081
(3001122) Ferritin [Mass/volume] in Serum or Plasma
267
2536
1.08
0.45
2.6
2.9
ug/l
183.1
182.4
0.01
242
2282
(3037467) Urinalysis macro (dipstick) panel - Urine
438
4525
0.93
0.44
3.5
4.5
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
35
414
0.84
0.43
2.5
3.1
e9/l
4.6
4.1
0.38
28
302
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
11
78
1.42
0.43
1.2
1.2
u/ml
2.0
6.3
—
5
33
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
16
122
1.32
0.42
1.1
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
6
92
0.65
0.42
2.0
2.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
21
167
1.26
0.42
1.7
3.0
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
49
426
1.16
0.42
2.2
2.9
e6/l
1.4
0.3
1.14
49
419
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
15
0.00
0.41
0.0
2.6
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
16
0.00
0.41
0.0
2.0
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(3009343) pH of Capillary blood
48
549
0.87
0.40
3.1
3.8
ph
7.4
7.4
—
6
75
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
91
828
1.11
0.40
1.5
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
52
589
0.88
0.39
3.3
4.0
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
453
4404
1.06
0.37
3.7
4.7
e6/l
206.4
2252.1
—
8
78
(3044889) 12 lead EKG panel
465
4775
0.94
0.37
5.2
4.4
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
59
659
0.89
0.36
1.6
1.8
%
2.0
1.7
0.68
43
543
(3009542) Hematocrit [Volume Fraction] of Blood
538
5499
0.94
0.36
36.8
18.6
%
34.8
39.4
22.04
370
3476
(40768793) Breast Pathology biopsy report
5
76
0.66
0.36
1.2
1.3
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
5
78
0.64
0.35
1.6
1.3
mosm/kgh2o
290.8
280.5
—
5
59
(3017817) Protein [Mass] in Urine collected for unspecified duration
5
79
0.63
0.35
1.6
2.5
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
43
378
1.14
0.33
3.9
4.1
%
47.8
47.6
0.02
43
373
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
6
47
1.28
0.32
1.0
1.1
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
17
137
1.25
0.32
1.4
1.3
mmol/l
73.7
62.7
0.61
12
117
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
11
83
1.33
0.32
1.0
2.0
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
7
53
1.32
0.31
1.0
1.3
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
7
53
1.32
0.31
1.0
1.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
46
515
0.89
0.31
2.5
4.3
%
1.1
0.4
1.93
17
145
(3006184) Hemoglobin [Mass/volume] in Capillary blood
15
185
0.81
0.30
2.8
2.3
g/l
121.5
129.5
—
10
139
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
12
94
1.28
0.28
1.4
1.6
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
12
94
1.28
0.28
1.4
1.6
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
25
215
1.17
0.27
4.4
4.8
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
12
95
1.27
0.26
1.4
1.6
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
104
976
1.07
0.26
1.9
2.5
%
1.9
1.8
0.34
91
873
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
5
72
0.69
0.26
1.0
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
138
1309
1.06
0.26
3.6
4.8
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
19
224
0.84
0.25
1.6
2.5
ug/min
152.6
117.4
0.20
11
132
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
9
74
1.22
0.25
1.1
1.9
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
9
74
1.22
0.25
1.1
1.9
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
9
74
1.22
0.25
1.1
1.9
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
6
82
0.73
0.24
1.2
1.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
88
826
1.07
0.23
6.4
3.9
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
10
79
1.27
0.22
1.0
2.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
34
378
0.90
0.22
3.6
3.8
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.1
—
38.3
—
0
10
(3050794) Legionella sp Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(4133840)
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
2.0
—
16.6
—
0
12
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
5
43
1.16
0.21
1.0
1.9
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
37
335
1.11
0.21
1.3
1.3
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
13
0.00
0.21
0.0
5.8
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
14
0.00
0.20
0.0
2.7
—
—
—
0
0
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
0
14
0.00
0.20
0.0
1.0
—
9.0
—
0
6
(3033923) Metanephrine [Moles/time] in 24 hour Urine
0
14
0.00
0.20
0.0
1.2
—
0.8
—
0
6
(3002619) Bacteria identified in Specimen by Culture
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
6
50
1.20
0.19
12.5
1.7
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
11
90
1.23
0.19
1.4
5.0
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
294
2869
1.04
0.19
13.4
10.9
e9/l
0.0
0.0
0.70
229
2356
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
7
59
1.19
0.18
1.4
1.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
62
581
1.07
0.18
2.3
4.4
%
1.1
0.7
0.90
27
202
(3015235) Bicarbonate [Moles/volume] in Capillary blood
21
237
0.88
0.18
3.3
2.9
mmol/l
27.6
24.9
1.59
16
203
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
11
91
1.21
0.17
1.5
1.7
—
—
—
0
0
(3011648) Oxygen content in Venous blood
7
61
1.15
0.17
1.4
2.0
%
8.0
11.3
—
7
61
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
5
67
0.74
0.17
1.0
1.2
u/l
50.0
55.7
—
5
47
(3025159) Blasts/100 leukocytes in Blood
48
514
0.93
0.16
2.5
4.5
%
0.0
0.1
1.32
18
159
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
20
178
1.13
0.15
1.1
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
11
93
1.19
0.14
1.5
1.7
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
20
179
1.12
0.14
1.2
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
20
180
1.11
0.13
1.2
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
15
169
0.89
0.12
2.7
2.7
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
12
136
0.88
0.11
2.2
2.1
mmol/l
1.6
1.7
0.05
12
131
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
5
45
1.11
0.10
1.6
1.6
u/l
11.8
13.4
—
5
22
(3051593) INR in Capillary blood by Coagulation assay
5
45
1.11
0.10
8.8
16.1
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
5
47
1.06
0.09
1.0
1.9
—
35.7
—
0
7
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
293
2965
0.98
0.08
3.7
4.1
ng/l
38.2
59.4
0.76
245
2332
(3004616) Nuclear Ab [Presence] in Serum
6
73
0.82
0.07
1.0
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
6
74
0.81
0.07
1.0
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
9
87
1.03
0.07
1.9
3.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
9
103
0.87
0.06
1.2
1.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
297
2996
0.99
0.05
2.1
2.1
pmol/l
83.6
92.5
2.77
182
1615
(3022313) Gas panel - Capillary blood
38
393
0.97
0.04
3.1
3.9
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
53
543
0.97
0.04
2.4
4.5
%
0.0
0.1
4.26
20
184
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
18
171
1.05
0.03
1.2
1.6
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
15
158
0.95
0.02
1.4
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
10
93
1.08
0.02
1.5
1.6
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
26
253
1.03
0.01
1.1
1.1
iu/ml
91.7
173.1
—
10
88
(3021879) Hepatitis B virus core Ab [Presence] in Serum
35
352
0.99
0.00
1.1
1.4
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
181
1814
1.00
0.00
1.6
1.6
nmol/l
19.1
20.0
0.44
169
1512
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
37
369
1.00
0.00
2.4
2.5
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
18
181
0.99
0.00
2.8
2.8
%
14.1
15.9
—
8
99
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
53
0.94
0.00
1.0
1.5
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
53
0.94
0.00
1.0
1.5
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
5.3
—
—
—
0
0
(3001729) Color of Synovial fluid
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
70
1.00
0.00
1.1
1.1
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.4
—
2.1
—
0
7
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
7
0.00
0.00
0.0
7.0
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
24.7
—
0
7
(3005011) Chlamydia sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
1.6
—
0
7
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
7
70
1.00
0.00
1.0
1.6
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(4281824)
5
51
0.98
0.00
1.2
1.2
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
4.5
—
—
—
0
0
(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.6
—
1027.4
—
0
5
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
10
100
1.00
0.00
1.0
1.0
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
2.4
—
0
5
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
5
0.00
0.00
0.0
4.4
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4212803)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
18.1
—
0
6
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
6
67
0.89
0.00
1.0
1.1
—
—
—
0
0
(3044416) Complement C4 [Mass/volume] in Pleural fluid
0
6
0.00
0.00
0.0
1.0
—
0.1
—
0
6
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
6
66
0.91
0.00
1.2
1.2
—
—
—
0
0
(4268621)
5
55
0.91
0.00
2.0
2.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
23
230
1.00
0.00
1.2
1.3
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
7.8
—
0
9
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
15
150
1.00
0.00
1.2
1.2
nmol/l
0.9
0.8
0.06
15
123
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
21
210
1.00
0.00
1.2
4.1
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
80.4
—
0
5
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
8
0.00
-0.00
0.0
2.8
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
8
0.00
-0.00
0.0
1.6
—
25.0
—
0
8
(3013762) Body weight Measured
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3026480) Teichoate Ab [Titer] in Serum
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
8
0.00
-0.00
0.0
1.5
—
99.9
—
0
8
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_OESOPHAGUS – Malignant neoplasm of oesophagus

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).